Trade Regulation

ORS 646A.696
Report to Health Care Cost Growth Target program and Legislative Assembly

  • contents of report


No later than December 31 of each year, the Prescription Drug Affordability Board shall report to the Health Care Cost Growth Target program established in ORS 442.386 (Health Care Cost Growth Target program established) and to the interim committees of the Legislative Assembly related to health, in the manner provided in ORS 192.245 (Form of report to legislature), the following information:

(1)

Price trends for the list of prescription drugs provided to the board by the Department of Consumer and Business Services under ORS 646A.694 (Annual affordability determination for identified drugs and insulin products) (1);

(2)

The prescription drugs that were reviewed under ORS 646A.694 (Annual affordability determination for identified drugs and insulin products) (1); and

(3)

Recommendations, if any, for legislative changes necessary to make prescription drug products more affordable in this state. [2021 c.598 §5]

Source

Last accessed
May 26, 2023